Cargando…
Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys
BACKGROUND: To determine where interventions are needed to eliminate trachoma as a public health problem, prevalence data are needed. We aimed to generate baseline population-based data on trachoma prevalence in suspected-endemic areas of Afghanistan. METHODS: Cross-sectional population-based preval...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581673/ https://www.ncbi.nlm.nih.gov/pubmed/35272540 http://dx.doi.org/10.1080/09286586.2021.2015784 |
_version_ | 1785122185312993280 |
---|---|
author | Salam, Ahmad Shah Qayumi, Rafiqullah Majeed Siddiqi, Abdul Naseem, Mohammad Mansoor, Mirwais Butcher, Robert Bakhtiari, Ana Renneker, Kristen Willis, Rebecca Jimenez, Cristina Dejene, Michael Safi, Naimullah Heggen, Anne Solomon, Anthony W. Harding-Esch, Emma M. Alizoi, Najeebullah |
author_facet | Salam, Ahmad Shah Qayumi, Rafiqullah Majeed Siddiqi, Abdul Naseem, Mohammad Mansoor, Mirwais Butcher, Robert Bakhtiari, Ana Renneker, Kristen Willis, Rebecca Jimenez, Cristina Dejene, Michael Safi, Naimullah Heggen, Anne Solomon, Anthony W. Harding-Esch, Emma M. Alizoi, Najeebullah |
author_sort | Salam, Ahmad Shah |
collection | PubMed |
description | BACKGROUND: To determine where interventions are needed to eliminate trachoma as a public health problem, prevalence data are needed. We aimed to generate baseline population-based data on trachoma prevalence in suspected-endemic areas of Afghanistan. METHODS: Cross-sectional population-based prevalence surveys designed according to World Health Organization (WHO) recommendations were conducted in 35 evaluation units (EUs) covering 72 districts. In selected households, all resident individuals aged ≥1 year were examined for trachomatous inflammation—follicular (TF) and trachomatous trichiasis (TT) according to the WHO simplified trachoma grading system. Water, sanitation and hygiene access was assessed in households of survey participants. RESULTS: 104,104 people aged ≥1 year were examined, including 43,774 children aged 1–9 years and 46,439 people aged ≥15 years. The age-adjusted prevalence of TF in 1–9-year-olds was ≥5% in 3 EUs, with the highest EU TF prevalence being 7.8%. The age- and gender-adjusted prevalence of TT unknown to the health system in ≥15-year-olds was <0.2% in all EUs. The majority of households had access to an improved water source within 30 minutes of the house. However, only a minority of households had an improved latrine and/or a handwash station. CONCLUSIONS: Trachoma is not a public health problem in the majority of EUs surveyed. However, antibiotic mass drug administration, promotion of facial cleanliness and environmental improvement (the A, F and E components of the SAFE strategy) are needed for trachoma elimination purposes in three of the EUs surveyed in Afghanistan. |
format | Online Article Text |
id | pubmed-10581673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-105816732023-10-18 Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys Salam, Ahmad Shah Qayumi, Rafiqullah Majeed Siddiqi, Abdul Naseem, Mohammad Mansoor, Mirwais Butcher, Robert Bakhtiari, Ana Renneker, Kristen Willis, Rebecca Jimenez, Cristina Dejene, Michael Safi, Naimullah Heggen, Anne Solomon, Anthony W. Harding-Esch, Emma M. Alizoi, Najeebullah Ophthalmic Epidemiol Research Article BACKGROUND: To determine where interventions are needed to eliminate trachoma as a public health problem, prevalence data are needed. We aimed to generate baseline population-based data on trachoma prevalence in suspected-endemic areas of Afghanistan. METHODS: Cross-sectional population-based prevalence surveys designed according to World Health Organization (WHO) recommendations were conducted in 35 evaluation units (EUs) covering 72 districts. In selected households, all resident individuals aged ≥1 year were examined for trachomatous inflammation—follicular (TF) and trachomatous trichiasis (TT) according to the WHO simplified trachoma grading system. Water, sanitation and hygiene access was assessed in households of survey participants. RESULTS: 104,104 people aged ≥1 year were examined, including 43,774 children aged 1–9 years and 46,439 people aged ≥15 years. The age-adjusted prevalence of TF in 1–9-year-olds was ≥5% in 3 EUs, with the highest EU TF prevalence being 7.8%. The age- and gender-adjusted prevalence of TT unknown to the health system in ≥15-year-olds was <0.2% in all EUs. The majority of households had access to an improved water source within 30 minutes of the house. However, only a minority of households had an improved latrine and/or a handwash station. CONCLUSIONS: Trachoma is not a public health problem in the majority of EUs surveyed. However, antibiotic mass drug administration, promotion of facial cleanliness and environmental improvement (the A, F and E components of the SAFE strategy) are needed for trachoma elimination purposes in three of the EUs surveyed in Afghanistan. Taylor & Francis 2022-03-10 /pmc/articles/PMC10581673/ /pubmed/35272540 http://dx.doi.org/10.1080/09286586.2021.2015784 Text en © 2022 World Health Organization. Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/3.0/igo/This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 IGO License (https://creativecommons.org/licenses/by/3.0/igo/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. This article shall not be used or reproduced in association with the promotion of commercial products, services or any entity. There should be no suggestion that the World Health Organization (WHO) endorses any specific organization, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article’s original URL. Disclaimer The authors are staff members of the World Health Organization and are themselves alone responsible for the views expressed in the Article, which do not necessarily represent the views, decisions, or policies of the World Health Organization or Taylor & Francis Group. |
spellingShingle | Research Article Salam, Ahmad Shah Qayumi, Rafiqullah Majeed Siddiqi, Abdul Naseem, Mohammad Mansoor, Mirwais Butcher, Robert Bakhtiari, Ana Renneker, Kristen Willis, Rebecca Jimenez, Cristina Dejene, Michael Safi, Naimullah Heggen, Anne Solomon, Anthony W. Harding-Esch, Emma M. Alizoi, Najeebullah Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys |
title | Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys |
title_full | Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys |
title_fullStr | Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys |
title_full_unstemmed | Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys |
title_short | Prevalence of Trachoma in 72 Districts of Afghanistan in 2018−2019: Results of 35 Population-based Prevalence Surveys |
title_sort | prevalence of trachoma in 72 districts of afghanistan in 2018−2019: results of 35 population-based prevalence surveys |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581673/ https://www.ncbi.nlm.nih.gov/pubmed/35272540 http://dx.doi.org/10.1080/09286586.2021.2015784 |
work_keys_str_mv | AT salamahmadshah prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT qayumirafiqullah prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT majeedsiddiqiabdul prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT naseemmohammad prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT mansoormirwais prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT butcherrobert prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT bakhtiariana prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT rennekerkristen prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT willisrebecca prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT jimenezcristina prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT dejenemichael prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT safinaimullah prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT heggenanne prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT solomonanthonyw prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT hardingeschemmam prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys AT alizoinajeebullah prevalenceoftrachomain72districtsofafghanistanin20182019resultsof35populationbasedprevalencesurveys |